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ANKRD1, the Gene Encoding Cardiac Ankyrin Repeat
Protein, Is a Novel Dilated Cardiomyopathy Gene
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Objectives We evaluated ankyrin repeat domain 1 (ANKRD1), the gene encoding cardiac ankyrin repeat protein (CARP), as
a novel candidate gene for dilated cardiomyopathy (DCM) through mutation analysis of a cohort of familial or
idiopathic DCM patients, based on the hypothesis that inherited dysfunction of mechanical stretch-based signal-
ing is present in a subset of DCM patients.
Background CARP, a transcription coinhibitor, is a member of the titin-N2A mechanosensory complex and translocates to the
nucleus in response to stretch. It is up-regulated in cardiac failure and hypertrophy and represses expression of
sarcomeric proteins. Its overexpression results in contractile dysfunction.
Methods In all, 208 DCM patients were screened for mutations/variants in the coding region of ANKRD1 using polymer-
ase chain reaction, denaturing high-performance liquid chromatography, and direct deoxyribonucleic acid se-
quencing. In vitro functional analyses of the mutation were performed using yeast 2-hybrid assays and investi-
gating the effect on stretch-mediated gene expression in myoblastoid cell lines using quantitative real-time
reverse transcription–polymerase chain reaction.
Results Three missense heterozygous ANKRD1 mutations (P105S, V107L, and M184I) were identified in 4 DCM pa-
tients. The M184I mutation results in loss of CARP binding with Talin 1 and FHL2, and the P105S mutation in
loss of Talin 1 binding. Intracellular localization of mutant CARP proteins is not altered. The mutations result in
differential stretch-induced gene expression compared with wild-type CARP.
Conclusions ANKRD1 is a novel DCM gene, with mutations present in 1.9% of DCM patients. The ANKRD1 mutations may
cause DCM as a result of disruption of the normal cardiac stretch-based signaling. (J Am Coll Cardiol 2009;54:
325–33) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.02.076T
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Hilated cardiomyopathy (DCM), a primary disorder of the
ardiac muscle characterized by ventricular chamber dilation
nd diminished cardiac contractility (1), is the most com-
See page 343
on cause of chronic heart failure (CHF) in the young and
he most common indication for cardiac transplantation (2).
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Familial inheritance is seen in30% to 40% of DCM patients
5). Autosomal dominant mode of inheritance is the most com-
on (90%), followed by X-linked (5% to 10%), autosomal
ecessive, and mitochondrial inheritance patterns (5%) (7). To
ate, mutations in 20 genes have been discovered in patients
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DCM-Associated ANKRD1 (CARP) Mutations July 21, 2009:325–33with DCM (8). Of these genes, the
genes encoding Z-band alternatively
spliced PDZ-motif protein, titin,
lamin A/C, and -myosin heavy
chain may each be responsible for
5% to 10% of familial DCM cases
(9–12), with dystrophin thought to
contribute in 10% to 15% of boys
with DCM (13).
Most of the known DCM-
causing mutations are thought to be
pathogenic due to resulting deficits
in force generation (beta-myosin
heavy chain, cardiac troponin T)
(14), force transmission (cardiac ac-
tin, alpha-tropomyosin, desmin,
dystrophin, delta-sarcoglycan, beta-
sarcoglycan) (15), or energy produc-
tion (mitochondrial mutations) (16).
Abnormal signaling in response to
force (abnormal stretch-based sig-
naling) is another potential mecha-
nism for inherited DCM that merits
further investigation.
We hypothesized that inherited
dysfunction of mechanical stretch-
sensing and stretch-based signal-
ng forms the pathogenic basis for a subset of DCM patients.
elethonin, cysteine- and glycine-rich protein 3 (CSRP3/
LP), and titin, which have been implicated in DCM
12,17,18), have a role in stretch-sensing and stretch-based
ignaling, in addition to their structural properties, and
bnormal mechanotransduction may be 1 of the mecha-
isms through which mutations in these proteins cause
CM. This hypothesis is further strengthened by the fact
hat targeted disruption in mice of genes such as 1-integrin
nd melusin, which have stretch-sensing functions, results in
CM (19,20).
Based on this hypothesis, we screened ankyrin repeat
omain 1 (ANKRD1), the gene encoding CARP, a tran-
cription cofactor that translocates to the nucleus in re-
ponse to mechanical stretch (21) and is up-regulated in
oth cardiac failure (22,23) and hypertrophy (24). CARP is
resent in the I-band region of the sarcomere as a member
f the titin-N2A mechanosensory unit (21). CARP is
nduced by mechanical stretch (21,25), - and -adrenergic
ignaling (26,27), and cytokines including transforming
rowth factor (TGF)- (28). Studies have shown that
ARP acts as a transcription coinhibitor and represses the
xpression of sarcomeric proteins, including myosin light
hain, cardiac troponin T, and myosin heavy chain species
29), and overexpression of CARP in engineered heart
issue causes contractile dysfunction (26).
In this study, we present the results of a comprehensive
utation screening of 208 patients with familial or idio-
Abbreviations
and Acronyms
ANKRD1  ankyrin repeat
domain 1
CARP  cardiac ankyrin
repeat protein
cDNA  complementary
deoxyribonucleic acid
CHF  chronic heart failure
DCM  dilated
cardiomyopathy
DNA  deoxyribonucleic
acid
FHL2  4-and-a-half LIM
domains 2
FS  fractional shortening
LVEDD  left ventricular
end-diastolic diameter
NYHA  New York Heart
Association
PCR  polymerase chain
reaction
RNA  ribonucleic acid
TGF  transforming growth
factorathic DCM for the presence of nonsynonymous sequence wariants in the coding region of ANKRD1, demonstrating
hat ANKRD1 is a novel DCM gene and that mutations in
NKRD1 occur in 2% of DCM patients. In addition, our
unctional analyses show that these mutations lead to
mpaired protein-protein interactions and altered gene ex-
ression in response to mechanical stretch, suggesting that
nherited dysfunction of stretch-based signaling is another
venue for the pathogenesis of DCM.
ethods
tudy patients. Genomic deoxyribonucleic acid (DNA)
rom 160 patients from the United Kingdom and 48
atients from Japan with familial or idiopathic DCM were
creened for mutations. DCM was diagnosed on the basis of
orld Health Organization/International Society and Fed-
ration of Cardiology Task Force criteria (1), and clinical
valuation of the patients was performed as previously
escribed (18). Genetic studies were performed blinded to
linical information. After written informed consent, blood
or DNA extraction was obtained, as regulated by the
nstitutional Review Boards at St. George’s Hospital Med-
cal School, London, United Kingdom, and the Baylor
ollege of Medicine, Houston, Texas, and the Ethics
eviewing Committee of Medical Research Institute, To-
yo Medical and Dental University, Tokyo, Japan.
utation screening. Peripheral blood-derived genomic
NA was used to amplify the 9 coding exons of ANKRD1
GenBank Accession no. NM_0143912) by polymerase
hain reaction (PCR) using primers derived from the
djoining intronic sequences (PCR primers and reaction
onditions available upon request). The PCR amplicons
ere analyzed using denaturing high-performance liquid
hromatography followed by direct sequencing, as previ-
usly described. Japanese samples were analyzed by direct
equencing of the PCR products.
onstruction of the wild-type and mutant ANKRD1
ectors. The full-length ANKRD1 complementary de-
xyribonucleic acid (cDNA) was inserted into pEGFP-C1
providing an N-terminal green fluorescent protein (GFP)
ag, Clontech BD Biosciences, Palo Alto, California) and
utations were introduced using the QuikChange XL
ite-Directed Mutagenesis Kit (Stratagene, La Jolla, Cali-
ornia). The ANKRD1 cDNA clones were sequenced com-
letely to confirm the presence of the desired mutation, the
bsence of cloning artifacts, and to ensure that the GFP and
NKRD1 coding sequences were in-frame. The wild-type
nd mutant ANKRD1 cDNAs were subcloned into a
cDNA 3.1 V5-His vector (Invitrogen, Carlsbad, Califor-
ia) to generate a C-terminal V5-His tagged fusion protein.
he fidelity of the subcloned fragment was confirmed by
irect DNA sequencing. The AdenoX system (Clontech,
alo Alto, California) was used for the generation of
eplication-incompetent adenoviral vectors carrying the
ild-type or mutant V5-His-tagged ANKRD1 cDNA.
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July 21, 2009:325–33 DCM-Associated ANKRD1 (CARP) Mutationsransfections and immunofluorescent detection of
FP. Cultured C2C12 mouse myoblastoid cells (American
ype Culture Collection, Manassas, Virginia) were transfected
ith the wild-type or mutant GFP tagged ANKRD1 cDNA
onstructs using Effectene (Qiagen, Valencia, California).
ells were fixed with cold 2% paraformaldehyde, permeabil-
zed with 0.25% Triton X-100 (Roche Applied Sciences,
ndianapolis, Indiana) after 48 h, and incubated with 4=,6-
iamidino-2-phenylindole dihydrochloride (DAPI, Invitro-
en) for nuclear staining and visualized by an Olympus
pifluorescence microscope.
east 2-hybrid assays. For yeast 2-hybrid mating studies,
ARP cDNAs were inserted into the pGBKT7 bait vector
BD Biosciences). We used CARP clones coding for
ild-type or mutant CARP as baits to qualitatively compare
heir interactions. As prey clones (inserted in pGADT7), we
sed a set of 39 genes: this gene set has been identified by
recent yeast 2-hybrid screen as coding for potential CARP
nteracting partners (S.H. Witt and S. Labeit, unpublished
ata, February 2009).
Technically, mating assays were performed as previously
escribed (21). Briefly, the wild-type and mutant CARP
DNA were subcloned into pBKT7 yeast 2-hybrid vectors
nd the recombinant baits transformed into Saccharomyces
erevisiae, strain AH109. The AH109 cells were cotrans-
ormed with recombinant library plasmids containing cDNAs of
ovel CARP-interacting ligands during a 2-hybrid survey of
ardiac and skeletal muscle prey libraries for novel CARP-
nteracting proteins. The transformed cells were incubated
or 5 days at 30°C on SD/Leu/Trp/His plates. Sub-
equent determination of -galactosidase activities were
erformed as described previously (21) and ligands with
ifferential binding between the wild-type and mutant
ARP proteins identified.
ene expression assays. Of the 3 disease-associated vari-
nts, the P105S and V107I variants were selected for the
ene expressions assays. The H9C2 cells (derived from
at embryonic myocardium) were plated in collagen-
Figure 1 DNA Sequencing of ANKRD1 Gene
Deoxyribonucleic acid (DNA) sequencing shows the P105S (left), V107L (middle),
and M184I (right) single nucleotide, heterozygous mutations in the ANKRD1 geneoated Flexcell stretchable 6-well plates at 80% density
nd transduced with first-generation adenoviral vectors
arrying V5-His-tagged wild-type or mutant ANKRD1
DNA, at 100 multiplicity of infection, as per manufac-
urer’s instructions (Clontech). Then, 48 h after trans-
uction, the cells in the stretchable plates were placed in
Flexcell 4000 unit (Hillsborough, North Carolina) in a
7oC incubator with the usual 5% CO2, and cyclically
tretched at a strain rate of 10% and a frequency of 60 Hz
or 6 h. The cells were then harvested and ribonucleic
cid (RNA) extracted using Trizol (Invitrogen) and
urified a second time using RNEasy columns (Qiagen).
rom each of the RNA samples, 150 ng of total RNA was
sed as a template in a quantitative real-time PCR
eaction, performed in an ABI Prism 7500 Sequence
etection System (Applied Biosystems) with SYBR
reen technology. The genes quantitated encode troponins
TNNT1, TNNT2, TNNT3, TNNC1), myosin species
MHY7, MLC2), myogenin (MYOG), P53 (TP53), calse-
uestrin (CASQ2), early growth response factor (EGR1),
trial natriuretic factor (NPPA), and TGF (TGFB1). In
ddition, a panel of 6 housekeeping genes (beta 2 micro-
lobulin, GAPDH, Eefig, Hmbs, Cyclophilin, and ALAS) was
hecked, and using Genorm software (Primer Design Ltd.,
outhampton, United Kingdom), the samples were normal-
zed to their starting template content.
esults
utation analysis of ANKRD1 gene. We identified 3
eterozygous, missense, sequence variants c.313CT
p.P105S), c. 319GT (p.V107L), and c.552GA (p.M184I)
n 4 Caucasian patients (Fig. 1): the P105S variant was
dentified in 2 patients. None of these variants was detected in
80 (360 chromosomes) ethnically-matched healthy normal
ontrol subjects and have not been reported in the dbSNP
atabase. No disease-associated mutations were found in Jap-
nese patients.
 dilated cardiomyopathy.. DCM
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DCM-Associated ANKRD1 (CARP) Mutations July 21, 2009:325–33Proline 105 and Valine 107 are located between the
uclear localization sequence and PEST (amino acids pro-
ine [P], glutamic acid [E], serine [S], threonine [T])
equence, a signal for degradation (Fig. 2A). Methionine
84 is located in the second ankyrin repeat domain, close to
he titin-N2A binding region of CARP (Fig. 2A). CARP is
ighly conserved across species, including at each of the 3
ffected residues (Fig. 2B).
linical characteristics of the probands with ANKRD1
ariants. All 4 patients carrying the variants were male.
ne proband with the P105S variant presented at the
ge of 15 years with a fractional shortening (FS) of
9% and left ventricular end-diastolic diameter
LVEDD) of 70 mm (Table 1). His father had isolated
Figure 2 CARP Amino Acid Residues Affected by Mutations
Location and conservation of the cardiac ankyrin repeat protein (CARP [ankyrin rep
P105S and V107L mutations are in exon 3 and between the nuclear localization r
close to the titin-N2A binding region of the second Ankyrin domain of ANKRD1. (B
linical Characteristics of DCM Probands With ANKRD1 MutationsTable 1 Clinical Characteristics of DCM Probands With ANKRD
Mutation Inheritance Age (yrs)
P105S Autosomal dominant 15
P105S Sporadic 52
V107L Sporadic 68
M184I Autosomal dominant 33NKRD1  ankyrin repeat domain 1; FS  fractional shortening; LVEDD  left ventricular end-diastolic deft ventricular dilation. The second proband with the
105S variant had no family history of DCM and
resented at the age of 52 years with an FS of 13% and
VEDD of 72 mm (Table 1). The proband with V107L
ariant also had no family history and presented at the
ge of 68 years with an FS of 12% and LVEDD of 61 mm
Table 1).
The proband carrying the M184I variant had a possible
utosomal-dominant inheritance. He presented at the age of
3 years with an FS of 10% and LVEDD of 83 mm (Table
). He had 1 affected sister with isolated left ventricular
ilation. The M184I variant was identified in the affected
ibling and his unaffected father. Family pedigrees of 3 of
he probands are shown in Figure 3.
main 1 (ANKRD1)]) amino acid residues affected by the mutations. (A) The
NLS) and PEST sequence of ANKRD1, while the M184I mutation is in exon 5
, V107, and M184 are evolutionally conserved amino acid residues of ANKRD1.
tations
Sex FS (%) LVEDD (mm)
Male 19 70
Male 13 75
Male 12 61
Male 10 83eat do
egion (
) P1051 Muimension.
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July 21, 2009:325–33 DCM-Associated ANKRD1 (CARP) Mutationsntracellular localization of CARP protein. The
resence of the substitutions in CARP did not alter
ts intracellular localization in undifferentiated C2C12
yoblastoid cells in the basal unstretched state or in
9C2 cells after cyclical stretch, with both wild-type and
utant proteins showing intranuclear and cytoplasmic
ocalization (Fig. 4), as previously reported for wild-type
ARP (21).
ifferential binding of the wild-type and mutant CARP
roteins using yeast 2-hybrid assays. The M184I muta-
ion resulted in a loss of binding of CARP with Talin-1
nd 4-and-a-half LIM domains 2 (FHL2). Talin-1 is a
70 kD protein located in the -integrin protein complex
nd plays an important role in binding the -integrin
ubunit with the cytoskeleton. FHL2 is a transcription
ofactor and is also located in the titin-N2B and
-integrin complexes. The P105S mutation results in loss
Figure 3 Families With DCM
Pedigree drawings of 3 dilated cardiomyopathy (DCM) families affected by ankyrin
indicate female family members; symbols with slash represent deceased persons
affected by DCM; and half-solid symbols represent persons with left ventricle enlaf CARP binding with Talin-1. No differential binding Tith respect to the wild-type protein was identified in the
107L mutation.
hanges in mechanical stretch-induced gene expression
fter wild-type and mutant CARP expression. Of the 3
CM-associated ANKRD1 variants, the P105S and V107L
ariants were selected for evaluation of mechanical stretch-
nduced gene expression compared with wild-type CARP.
he P105S substitution enhanced the down-regulation of
53 and up-regulation of myogenin seen after transduction
ith wild-type CARP (Fig. 5), suggesting a gain of function
ffect. In contrast, the V107L substitution blocked the
ecreased expression of TGFBR1 and CASQ2 seen in the
ild-type expressing cells (Fig. 5). However, this substitu-
ion enhanced the down-regulation of EGR1 seen in the
ild-type cells and decreased the expression of TNNT1,
hich was up-regulated in wild-type cells (Fig. 5). The
xpression of other isoforms of troponin T (TNNT2 and
domain 1 (ANKRD1) mutations. Squares indicate male family members; circles
symbols represent unaffected persons; solid symbols represent persons
nt. Probands are identified by arrows.repeat
; open
rgemeNNT3) was, however, not changed.
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DCM-Associated ANKRD1 (CARP) Mutations July 21, 2009:325–33iscussion
NKRD1 is a novel DCM gene. Our data indicate that
NKRD1 (encoding cardiac ankyrin repeat protein) is a
ovel disease gene in DCM, with variants identified in 4
f 208 (1.9%). The 3 nonsynonymous ANKRD1 variants
P105S, V107L, and M184I) were identified only in the
atient cohort, resulted in the substitution of conserved
mino acid residues, and altered protein–protein interac-
ions and/or stretch-induced gene expression, suggest-
ng that they are disease causing. The prevalence of
NKRD1 mutations in our DCM patient cohort is
onsistent with the published mutation prevalence data
or most of the other known DCM-associated genes that
ary from 1% to 3% (except MHC7, titin, LMNA, and
DB3, which may each account for 5% to 10% of DCM
ases).
he role of CARP in cardiac hypertrophy and failure.
ince its discovery in 1995, the ANKRD1 gene and its
ranscript CARP have elicited significant interest as one of
he transcripts found to be persistently up-regulated in
ardiac hypertrophy and heart failure, although its exact role
n these conditions is not yet clear. CARP is predominantly
xpressed in cardiac muscle, with lower expression levels in
keletal muscle and endothelial cells. It is one of the earliest
arkers of cardiac muscle cell lineage and is downstream in
he Nkx2.5 pathway that defines the early heart field in the
eveloping embryo (30). The high level of ventricular
ARP expression in the fetal heart, down-regulation in the
dult ventricle, and significant up-regulation during cardiac
ypertrophy (24) indicates that CARP is part of the
evelopmentally regulated fetal gene program (31). CARP
as been shown to be a transcription coinhibitor and
ecreases the expression of myocyte contractile elements
ncluding cardiac actin, skeletal actin, and myosin light
Figure 4 Cytosolic and Nuclear Localization of CARP Protein
Cytosolic and nuclear localization of wild-type (WT), P105S, V107L, and M184I mu
tagged wild-type or mutant ANKRD1 complementary deoxyribonucleic acid (cDNA) i
stretch.hain 2V (29). Adenoviral-mediated transduction of C2/C2 cells with CARP decreases overall DNA synthe-
is, indicating that CARP may play a role in decreasing
ellular proliferation. In addition, overexpression of
ARP in engineered cardiac tissue results in contractile
ysfunction (26).
ignificance of altered protein–protein interactions of
he P105S and M184I substitutions. Both the P105S and
184I substitutions result in loss of CARP binding with
alin 1. Talin 1 is a key binding partner of the beta-integrin
ubunit of the integrin-complex (which connects the extra-
ellular matrix with the intracellular cytoskeleton and is a
utative cellular mechanosensory unit). Hence, disruption
f the CARP-Talin 1 interaction may result in altered
echanical stretch-based signaling. In addition to loss of
alin 1 binding, the M184I substitution also results in loss
f CARP interaction with the FHL2 protein. The FHL2
rotein is highly expressed in the heart and binds to the
2B domain of titin, which has potential stretch-sensing
unctions. FHL2 may have dual roles, acting both as an
daptor protein as well as a transcription coactivator and
electively increases the transcriptional activity of the andro-
en receptor. Recently, an FHL2 variant that significantly
ecreased FHL2 binding with the titin-N2B segment was
eported in a DCM patient (32). Similarly, a DCM-
ssociated mutation has been reported in the titin-N2B
egion (12). These findings together indicate that interac-
ion between the stretch-based signaling molecules is im-
ortant in the functional integrity of the cardiomyocyte, and
isruption of this interaction may be one of the pathways to
CM.
mplication of the gene-expression changes due to the
NKRD1 mutations in the pathogenesis of DCM. The
105S variant resulted in down-regulation of p53 and
p-regulation of myogenin compared with wild-type
ardiac ankyrin repeat protein (CARP) protein is similar after transfection with GFP-
2C12 cells in basal resting state and (B) H9C2 cells after cyclic mechanicaltant c
n (A) CARP, and the V107L variant up-regulated the expression
o
a
C
r
T
c
d
p
o
s
T
C
w
i
c
(
e
m
e
i
r
d
h
d
t
C
i
a
B
o
i
c
r
c
331JACC Vol. 54, No. 4, 2009 Moulik et al.
July 21, 2009:325–33 DCM-Associated ANKRD1 (CARP) Mutationsf TGF1 and calsequestrin 2, and down-regulated EGR1
nd slow isoform of troponin T compared with wild-type
ARP. The significance of these findings and any potential
ole in the pathogenesis of DCM still needs to be evaluated.
he oncogene p53 has been implicated in cardiomyocyte
ell cycle control and apoptosis (33). Myogenin, a muscle
ifferentiation factor, also inhibits cell division and may
revent the remodeling (34) that normally occurs in the
verloaded heart. TGF is a potent stimulator of collagen
ynthesis by cardiac fibroblasts (35), and elevated levels of
GF are seen in patients with idiopathic DCM (36).
alsequestrin serves as the major calcium ion reservoir
ithin the sarcoplasmic reticulum of cardiac myocytes, and
ts overexpression causes an abnormal sequestration of
alcium, leading to dysregulated EC-coupling in the heart
37). EGR1, a transcription factor and one of the immediate
arly response genes, is induced in alpha-adrenergic–
Figure 5 Gene Expression Changes
Gene expression changes in H9C2 cells transduced with wild-type (WT) or mutant
(A) Expression of p53 is down-regulated (p  0.03) and (B) myogenin expression
ANKRD1 cDNA. As shown in (C) transforming growth factor (TGF)-beta1, (D) CASQ2
EGR1 and TNNT1 are down-regulated (p  0.05) in cells transduced with V107L cediated myocardial hypertrophy (38) and regulates the
xpression of -myosin heavy chain (39). Isoforms shift
n troponin T, a subunit of the troponin complex that
egulates actin-myosin cross-bridge formation, has been
escribed in several animal models and various forms of
eart failure, with expression of a fetal isoform in the
iseased state (40). Hence, we speculate that in response
o mechanical stretch, the DCM-associated mutations in
ARP may result in altered expression of proteins
nvolved in key cellular pathways such as cell cycle,
poptosis, growth, and cytokine or calcium signaling.
ecause our experiments were performed in a rat embry-
nic heart cell line, H9C2, some caution needs to be used
n extrapolating these results to DCM patients without
onfirming them in other model systems more closely
epresentative of the myocardial milieu, such as primary
ardiomyocyte cultures.
1 complementary deoxyribonucleic acid (cDNA) and cyclically stretched for 6 h.
egulated (p  0.01) in cells transduced with P105S compared with wild-type
GR1, and (F) TNNT1, TGF-beta1 and CASQ2 are up-regulated (p  0.05) and
ed with wild-type ANKRD1 cDNA.ANKRD
is up-r
, (E) E
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DCM-Associated ANKRD1 (CARP) Mutations July 21, 2009:325–33nherited dysfunction of stretch-based signaling, another
aradigm for the pathogenesis of familial DCM. Most of
he proteins encoded by the known DCM-causing genes are
tructural components of the sarcolemma, cytoskeleton, or
arcomere involved in force transmission or force genera-
ion, and hence they form the basis for our earlier hypothesis
hat the linkage of the sarcolemma, cytoskeleton, and
arcomere would comprise the “final common pathway” of
CM (41). However, with the recent additions to the
ver-lengthening list of DCM-causing genes, it is increas-
ngly apparent that DCM is genetically the most heteroge-
eous of all the primary cardiomyopathies and inherited
ardiac disorders. A subset of the DCM-causing genes
ncode proteins involved in cellular stretch-based signaling,
ncluding MLP (42), FHL2 (32), -crystallin (43), and
cap (17), and mutations in these genes may result in DCM
y interfering with stretch-based signaling. ANKRD1 be-
ongs to this subset of DCM-causing genes. Hence, we
ropose that inherited dysfunction of stretch-based signal-
ng is another paradigm for the pathogenesis of familial
CM. Candidate gene screening based on this paradigm
ay result in the identification of additional novel DCM-
ausing genes.
onclusions
n summary, ANKRD1, the gene encoding CARP (a
ranscription cofactor with presumed stretch-based signal-
ng function), is a novel DCM gene, and genetic variants
ccount for 1.9% of cases. DCM-associated variants in
NKRD1 result in dysfunction of the cellular stretch-based
ignaling machinery, suggesting that these are disease caus-
ng, and provide support to the hypothesis that inherited
ysfunction of cardiac stretch-based signaling is present in a
ubset of DCM patients.
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